BELOTTI DANIELA

Pubblicazioni

  • Magnani, C., Gaipa, G., Lussana, F., Belotti, D., Gritti, G., Napolitano, S., et al. (2020). Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities. THE JOURNAL OF CLINICAL INVESTIGATION, 130(11), 6021-6033 [10.1172/JCI138473]. Dettaglio
  • Introna, M., Lussana, F., Algarotti, A., Gotti, E., Valgardsdottir, R., Micò, C., et al. (2017). Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23(12), 2070-2078 [10.1016/j.bbmt.2017.07.005]. Dettaglio
  • BELOTTI, D., GAIPA, G., Bassetti, B., Cabiati, B., Spaltro, G., BIAGI, E., et al. (2015). Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy. BIOMED RESEARCH INTERNATIONAL, 2015 [10.1155/2015/473159]. Dettaglio
  • Introna, M., Lucchini, G., Dander, E., Galimberti, S., Rovelli, A., Balduzzi, A., et al. (2014). Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(3), 375-381 [10.1016/j.bbmt.2013.11.033]. Dettaglio
  • Introna, M., Lucchini, G., Dander, E., Rovelli, A., Balduzzi, A., Longoni, D., et al. (2012). Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients. BLOOD, 120(21). Dettaglio